Vista Capital Partners, Inc. Alpine Immune Sciences, Inc. Transaction History

Vista Capital Partners, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$8.81 - $15.03 $126,018 - $214,989	-14,304 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$10.02 - $13.92 $200,400 - $278,400	-20,000 Reduced 58.3%	14,304 $152,000
Q4 2020 Feb 10, 2021	BUY	$7.42 - $15.96 $254,535 - $547,491	34,304 New	34,304 $432,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Vista Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Vista Capital Partners, Inc. with notifications on news.